Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Cost-effectiveness
100%
Long-term Health Outcomes
100%
Microsimulation Model
100%
Outcome Costs
100%
Quality-adjusted Life Years
66%
Hemoglobin A1c (HbA1c)
33%
External Validation
33%
Medical Costs
33%
Internal Validation
33%
US Adults
33%
Outcome Prediction
16%
Clinical Trials
16%
Prediction Accuracy
16%
United States
16%
Clinical Intervention
16%
Cost Impact
16%
Intervention Effectiveness
16%
Health Effects
16%
Oral Medication
16%
Long-term Health Effects
16%
Mortality Factors
16%
Public Health Interventions
16%
Incremental Cost-effectiveness Ratio
16%
US Population
16%
Treatment Utility
16%
Lifetime Healthcare Costs
16%
Average Absolute Difference
16%
Medicine and Dentistry
Health Care Cost
100%
Maturity Onset Diabetes of the Young
100%
Health Outcomes
100%
Cost-Effectiveness Analysis
100%
Quality Adjusted Life Year
57%
Hemoglobin A1c
28%
Clinical Trial
14%
Public Health
14%
Lifespan
14%
Observational Study
14%
Clinical Intervention
14%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Non Insulin Dependent Diabetes Mellitus
100%
Health Outcomes
100%
Quality Adjusted Life Year
66%
Health Economics
50%
Hemoglobin A1c
33%
Incremental Cost-Effectiveness Ratio
16%
Nutrition Policy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Hemoglobin A1c
33%
Observational Study
16%
Clinical Trial
16%